EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:231679 - ipilimumab
| ChEBI ID | CHEBI:231679 |
| ChEBI Name | ipilimumab |
| Stars | |
| Definition | Ipilimumab is a human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma.(DrugBank) |
| Submitter | amillett1 |
| Roles Classification |
|---|
| Biological Roles: | antiviral agent A substance that destroys or inhibits replication of viruses. anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ipilimumab (CHEBI:231679) has role anti-HIV agent (CHEBI:64946) |
| ipilimumab (CHEBI:231679) has role antineoplastic agent (CHEBI:35610) |
| ipilimumab (CHEBI:231679) has role antiviral agent (CHEBI:22587) |
| ipilimumab (CHEBI:231679) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| BMS-734016 | ChEMBL |
| BMS734016 | ChEMBL |
| Ipilimumab | ChEMBL |
| MDX-010 | SUBMITTER |
| MDX010 | ChEMBL |
| MDX-010 MDX-CTLA4 | ChEMBL |
| Brand Name | Source |
|---|---|
| Yervoy | ChEMBL |